---
title: "Pyxis Oncology surges 16% as MICVO Phase I shows 39% response rate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306292977.md"
description: "Pyxis Oncology surged 16% to $1.95 after MICVO Phase I data showed a 39% confirmed response rate and 6.7-month mPFS."
datetime: "2026-11-20T15:15:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306292977.md)
  - [en](https://longbridge.com/en/news/306292977.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306292977.md)
generator: "portal-rs"
---

# Pyxis Oncology surges 16% as MICVO Phase I shows 39% response rate

Pyxis Oncology (PYXS.US) surged more than **16%** during regular trading to **$1.95**.

The biotechnology industry index rose 1.5% over the same period.

The company reported updated Phase I trial data for MICVO in 33 patients with second-line or later recurrent or metastatic head and neck squamous cell carcinoma, showing a confirmed objective response rate of **39%**, a disease control rate of **94%**, median progression-free survival of **6.7 months**, median duration of response of **9.2 months** and a 12-month overall survival probability of **79%**. Pyxis said the data support its planned global Phase III HeadlinerSM clinical trial scheduled to begin in mid-2027.

Separately, Pyxis narrowed its third-quarter net loss as expenses declined. Previously reported data for MICVO monotherapy in advanced head and neck cancer showed a confirmed response rate of **36%** and median progression-free survival of **6.2 months**.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)

## Related News & Research

- [PYXS: MICVO showed durable responses in phase 1, supporting a planned global Phase 3 trial](https://longbridge.com/en/news/306107284.md)
- [William Blair upgrades Pyxis Oncology to Outperform from Market Perform](https://longbridge.com/en/news/306274949.md)
- [Guggenheim Remains a Buy on Pyxis Oncology (PYXS)](https://longbridge.com/en/news/306281515.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**